1. Home
  2. Author: Michael Zand

All posts by: Michael Zand

About Michael Zand

UTHealth starts clinical trial to study two forms of stem cell treatments for … – News-Medical.net

UTHealth starts clinical trial to study two forms of stem cell treatments for …News-Medical.netA first-of-its-kind clinical trial studying two forms of stem cell treatments for children with cerebral palsy (CP) has begun at The University of Texas Health Science Center at Houston (UTHealth) Medical School. The double-blinded, placebo-controlled …UTHealth Researchers Study Stem Cell Treatments for … Continue reading

2013-12-11 NEWS

UTHealth Researchers Study Stem Cell Treatments for Children with CP – Newswise (press release)

UTHealth Researchers Study Stem Cell Treatments for Children with CPNewswise (press release)Newswise — HOUSTON – (Dec. 10, 2013) – A first-of-its-kind clinical trial studying two forms of stem cell treatments for children with cerebral palsy (CP) has begun at The University of Texas Health Science Center at Houston (UTHealth) Medical School.Weighing Cord Blood Donation Against … Continue reading

2013-12-10 NEWS

Breakthrough in treating leukemia, lymphoma patients with umbilical cord blood … – Science Daily (press release)

Science Daily (press release)Dec. 9, 2013 — A study lead by a Loyola University Medical Center oncologist has found that growing cord blood stem cells in a laboratory before transplanting them into patients significantly improves survival.Growing cord blood stem cells in lab before transplant boosts survival, study …News-Medical.net“Breakthrough” for blood cancer treatmenteMaxHealth all 8 news … Continue reading

2013-12-10 NEWS

Celldex’s CDX-301 in Combination with Mozobil(R) Increases Hematopoietic … – GlobeNewswire (press release)

Celldex’s CDX-301 in Combination with Mozobil(R) Increases Hematopoietic …GlobeNewswire (press release)“We need novel interventions to advance hematopoietic stem cell mobilization techniques and transplantation, and based on our studies to date, this could be a promising alternative approach for these patients,” said Steven Devine, MD, Professor of … and more …read more   &nbs… Continue reading

2013-12-10 NEWS